Second-dose VITT: rare but real
In the current issue of Blood, Krzywicka et al convincingly show for the first time, that vaccine-induced immune thrombocytopenia and thrombosis (VITT) can occur after a second dose of the AstraZeneca/Oxford ChAdOx1 nCoV-19 vaccine.